Healthcare provider profile · identity verified

Sharon L. Chaffee, MD

Family Practice · MENTOR, OH · NPI 1528562873

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Jardiance	Empagliflozin	155	36
Atorvastatin Calcium	Atorvastatin Calcium	151	34
Omeprazole	Omeprazole	111	26
Levothyroxine Sodium	Levothyroxine Sodium	94	17
Amlodipine Besylate	Amlodipine Besylate	91	21
Pantoprazole Sodium	Pantoprazole Sodium	90	16
Gabapentin	Gabapentin	84	19
Albuterol Sulfate Hfa	Albuterol Sulfate	80	25
Metformin Hcl Er	Metformin Hcl	80	23
Lisinopril	Lisinopril	70	17
Trulicity	Dulaglutide	62	13
Losartan Potassium	Losartan Potassium	59	16
Famotidine	Famotidine	52	suppressed
Fluticasone Propionate	Fluticasone Propionate	50	23
Rosuvastatin Calcium	Rosuvastatin Calcium	50	15
Meloxicam	Meloxicam	49	18
Oxybutynin Chloride Er	Oxybutynin Chloride	46	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	46	suppressed
Furosemide	Furosemide	45	11
Topiramate	Topiramate	45	suppressed
Methocarbamol	Methocarbamol	38	14
Montelukast Sodium	Montelukast Sodium	38	suppressed
Potassium Chloride	Potassium Chloride	38	suppressed
Prednisone	Prednisone	38	23
Ondansetron Odt	Ondansetron	35	11
Metformin Hcl	Metformin Hcl	34	suppressed
Trazodone Hcl	Trazodone Hcl	32	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Tramadol Hcl	Tramadol Hcl	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Ibuprofen	Ibuprofen	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Ozempic	Semaglutide	27	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Metoprolol Succinate	Metoprolol Succinate	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	21	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Baclofen	Baclofen	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	15
Fluconazole	Fluconazole	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Carvedilol	Carvedilol	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Dulera	Mometasone/Formoterol	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Rivastigmine	Rivastigmine Tartrate	15	suppressed
Single Use Swab	Alcohol Antiseptic Pads	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Linzess	Linaclotide	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Simvastatin	Simvastatin	12	suppressed
Torsemide	Torsemide	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error